Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H16O3 |
| Molecular Weight | 232.275 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=O)O[C@@H](CCC2=CC=CC=C2)C1
InChI
InChIKey=VOOYTQRREPYRIW-LBPRGKRZSA-N
InChI=1S/C14H16O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-6,10,12H,7-9H2,1H3/t12-/m0/s1
| Molecular Formula | C14H16O3 |
| Molecular Weight | 232.275 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12494336
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12494336
Dihydrokavain (or DIHYDROKAWAIN) is one of the six major kavalactones found in the kava plant. It was shown that dihydrokavain might play an important role in regulation of GABAergic neurotransmission, because this compound can modulate the brainstem GABAergic mechanism.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GABAergic activity Sources: https://www.ncbi.nlm.nih.gov/pubmed/12494336 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1. | 2011-12 |
|
| Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. | 2010-10-07 |
|
| Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex. | 2010-08-01 |
|
| Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. | 2009-08 |
|
| Efficient enantioselective hetero-Diels-Alder reaction of Brassard's diene with aliphatic aldehydes: a one-step synthesis of (R)-(+)-kavain and (S)-(+)-dihydrokavain. | 2008-03-20 |
|
| Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. | 2006-04-14 |
|
| Fourier transform ion cyclotron resonance mass spectrometry for the characterisation of kavalactones in the kava plant: elemental formulae confirmation by dual spray accurate mass measurement and structural confirmation by infrared multiphoton dissociation and sustained off-resonance irradiation collision induced dissociation. | 2006 |
|
| Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. | 2005-11 |
|
| Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard. | 2005-03-12 |
|
| Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. | 2005-03-04 |
|
| Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. | 2003-03 |
|
| Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation. | 2002-12 |
|
| Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). | 2002-12 |
|
| Interaction of various Piper methysticum cultivars with CNS receptors in vitro. | 2001-06 |
|
| Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. | 2001-04 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12494336
Pretreatment with dihydrokavain (300 uM) significantly decreased the nucleus tractus solitarius (NTS) inhibitory effects induced by muscimol (30 uM), approximately from 51 % to 36 %. Dihydrokavain induced inhibitory effects was not reduced after co-application of saclofen or naloxone.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:20:50 GMT 2025
by
admin
on
Mon Mar 31 22:20:50 GMT 2025
|
| Record UNII |
NW8ZGW9XRZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
2592 (Number of products:13)
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DIHYDROKAVAIN
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | |||
|
112163
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | |||
|
587-63-3
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | |||
|
m6605
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
NW8ZGW9XRZ
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | |||
|
10220256
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY | |||
|
DTXSID8033433
Created by
admin on Mon Mar 31 22:20:50 GMT 2025 , Edited by admin on Mon Mar 31 22:20:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |